We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$5.74B
AUM Growth
+$541M
Cap. Flow
+$341M
Cap. Flow %
5.94%
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Avg Time Held Equity + Options
0.4 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$67M
2
INDA icon
iShares MSCI India ETF
INDA
+$55.1M
3
AAPL icon
Apple
AAPL
+$50.9M
4
INTU icon
Intuit
INTU
+$43.3M
5
LOW icon
Lowe's Companies
LOW
+$41.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 15.3%
2 Consumer Discretionary 13.6%
3 Technology 11.89%
4 Healthcare 11.31%
5 Industrials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CERS icon
1976
Cerus
CERS
$374M
$86K ﹤0.01%
+25,440
New +$86.1K
2017 Q4
0 quarters
NAT icon
1977
Nordic American Tanker
NAT
$1.32B
$86K ﹤0.01%
35,112
+16,735
+91% +$69.2K
2017 Q3
1 quarter
CLDX icon
1978
Celldex Therapeutics
CLDX
$2.15B
$85K ﹤0.01%
2,007
-477
-19% -$20.4K
2017 Q3
1 quarter
GPL
1979
DELISTED
Great Panther Mining
GPL
$85K ﹤0.01%
6,564
+243
+4% +$2.95K
2016 Q4
4 quarters
CLAR icon
1980
Clarus
CLAR
$182M
$83K ﹤0.01%
+10,606
New +$79.6K
2017 Q4
0 quarters
PIM icon
1981
Franklin Master Intermediate Income Trust
PIM
$142M
$83K ﹤0.01%
+17,500
New +$83.1K
2017 Q4
0 quarters
NDLS icon
1982
Noodles & Co
NDLS
$50M
$82K ﹤0.01%
+1,957
New +$75K
2017 Q4
0 quarters
RUN icon
1983
Sunrun
RUN
$1.6B
$81K ﹤0.01%
+13,767
New +$79.1K
2017 Q4
0 quarters
RCM icon
1984
DELISTED
R1 RCM
RCM
$80K ﹤0.01%
+18,150
New +$71K
2017 Q4
0 quarters
KEYW
1985
DELISTED
KEYW Holding
KEYW
$78K ﹤0.01%
+13,345
New +$83.6K
2017 Q4
0 quarters
GAU icon
1986
Galiano Gold
GAU
$451M
$75K ﹤0.01%
105,934
-334,067
-76% -$271K
2017 Q1
3 quarters
PIR
1987
DELISTED
Pier 1 Imports
PIR
$75K ﹤0.01%
+910
New +$80.9K
2017 Q4
0 quarters
SID icon
1988
Companhia Siderúrgica Nacional
SID
$676M
$74K ﹤0.01%
30,012
+7,239
+32% +$18.7K
2016 Q4
4 quarters
TNTR
1989
DELISTED
Tintri
TNTR
$74K ﹤0.01%
+14,462
New +$64.5K
2017 Q4
0 quarters
CLNE icon
1990
Clean Energy Fuels
CLNE
$337M
$73K ﹤0.01%
+36,074
New +$79.7K
2017 Q4
0 quarters
SOHO
1991
DELISTED
Sotherly Hotels
SOHO
$72K ﹤0.01%
+11,100
New +$70.9K
2017 Q4
0 quarters
ARAY icon
1992
Accuray
ARAY
$6.24M
$71K ﹤0.01%
+411
New +$75.5K
2017 Q4
0 quarters
FATE icon
1993
Fate Therapeutics
FATE
$112M
$70K ﹤0.01%
+11,397
New +$50.9K
2017 Q4
0 quarters
ABUS icon
1994
Arbutus Biopharma
ABUS
$616M
$69K ﹤0.01%
13,600
+3,300
+32% +$19.3K
2017 Q3
1 quarter
AETR icon
1995
Aetherion Technologies
AETR
$28.5M
$68K ﹤0.01%
+1,804
New +$58.7K
2017 Q4
0 quarters
AT icon
1996
DELISTED
Atlantic Power
AT
$64K ﹤0.01%
+27,291
New +$67K
2017 Q4
0 quarters
AGRX
1997
DELISTED
Agile Therapeutics
AGRX
$63K ﹤0.01%
12
-6
-33% -$55.9K
2017 Q3
1 quarter
ALTO icon
1998
Alto Ingredients
ALTO
$231M
$61K ﹤0.01%
+13,514
New +$64.1K
2017 Q4
0 quarters
AGTC
1999
DELISTED
Applied Genetic Technologies
AGTC
$61K ﹤0.01%
16,900
-28,800
-63% -$109K
2016 Q4
4 quarters
MR
2000
DELISTED
Montage Resources
MR
$61K ﹤0.01%
+1,699
New +$61.4K
2017 Q4
0 quarters

Similar funds

Squarepoint's Q4 2017 Portfolio in Review

As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Squarepoint deployed $341M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.

  • Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
  • Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
  • Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
  • Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
  • Squarepoint opened 949 new positions and closed 486 in Q4 2017.
  • Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.

Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.